Literature DB >> 29018029

New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management.

Nicole V Tolan1, Gary L Horowitz2, Camilla S Graham3, David Hillyard4, William Osburn5, Stuart Ray6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29018029     DOI： 10.1373/clinchem.2016.266569

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  2 in total

Review 1.  Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2.

Authors:  Nicole V Tolan; Gary L Horowitz
Journal:  Clin Lab Med       Date:  2022-03-04       Impact factor: 2.172

2.  The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations.

Authors:  Yanfang Huang; Huifen Pan; Qin Gao; Panpan Lv; Xiaoqin Xu; Zhen Zhao
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.